Thromb Haemost 1983; 50(03): 690-696
DOI: 10.1055/s-0038-1665289
Original Article
Schattauer GmbH Stuttgart

Standardization of Factor VIII – III. Establishment of a Stable Reference Plasma for Factor VIII-Related Activities

T W Barrowcliffe
The National Institute for Biological Standards and Control, London, U.K.
,
M S Tydeman
The National Institute for Biological Standards and Control, London, U.K.
,
T B L Kirkwood
*   The National Institute for Medical Research, London, U.K.
,
D P Thomas
The National Institute for Biological Standards and Control, London, U.K.
› Author Affiliations
Further Information

Publication History

Received 02 March 1983

Accepted 25 July 1983

Publication Date:
26 July 2018 (online)

Summary

An international collaborative study has been carried out to establish a reference plasma for Factor VIII-related activities. The freeze-dried reference plasma, coded 80/511, was assayed against fresh normal plasma, local standards and another freeze- dried plasma. There was good agreement between laboratories for the comparison of the two freeze-dried plasmas, but wide variation in the comparison of plasma 80/511 with fresh normal plasma and local standards, indicating the differences in Factor VIII content of local pooled plasmas. There were no significant differences between the one-stage and two-stage assays of VIII :C, or between electroimmunoassay (EIA) and immuno- radiometric (IRMA) assays of VIII R:Ag. However, in VIII R: RCoF (ristocetin co-factor) assays, the aggregometry methods gave lower values than the macroscopic and counting methods for the comparison of freeze-dried against fresh normal plasmas. From the combined results of assays against each laboratory’s fresh normal plasma, potencies were assigned to plasma 80/511.

Results from accelerated degradation studies indicated that losses of each VIII-related activity in plasma 80/511, when stored at -20° C, should be less than 0.01% per year, indicating its suitability to serve as a long-term reference preparation. Plasma 80/511 has been established by the WHO Expert Committee on Biological Standardization as the 1st International Reference Preparation for Factor VIII-Related Activities in Plasma.

 
  • References

  • 1 Bangham DR, Biggs R, Brozovic M, Denson KW, Skegg JL. A biological standard for measurement of blood coagulation Factor Vm activity. Bull Wld Hlth Org 1971; 45: 331-351
  • 2 World Health Organization Technical Reports Series. 1971; 463: 14
  • 3 Barrowcliffe TW, Kirkwood TB. An international collaborative assay of Factor VIII clotting activity. Thromb Haemostas 1978; 40: 260-271
  • 4 Kirkwood TB, Barrowcliffe TW. Discrepancy between one-stage and two-stage assay of Factor VIII:C. Br J Haematol 1978; 40: 333-338
  • 5 Barrowcliffe TW, Kirkwood TB L. Standardization of Factor VIII. In: Calibration of British standards for VIII clotting activity Br J Haematol 1980; 46: 471-481
  • 6 Kirkwood TB, Rizza CR, Snape TJ, Rhymes I, Austen DE G. Identification of sources of inter-laboratory variation in Factor VIII assay. Br J Haematol 1977; 37: 559-568
  • 7 Barrowcliffe TW, Kirkwood TB L, Rizza CR. Aluminium hydroxide adsorption and Factor VIII clotting assays. Lancet 1980; 1: 820
  • 8 Campbell PJ. International biological standards and reference preparations. II: Procedures used for the production of biological standards and reference preparations. J Biol Stand 1974; 2: 259-267
  • 9 Laurell C-B. Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies. Anal Biochem 1966; 15: 45-52
  • 10 Brinkhous KM, Graham JE, Cooper HA, Allain JP, Wagner RH. Assay of von Willebrand factor in von Willebrand’s disease and haemophilia. Use of a macroscopic platelet aggregation test Thromb Res 1975; 6: 267-272
  • 11 Evans RJ, Austen DE G. Assay of ristocetin co-factor using fixed platelets and a platelet counting technique. Br J Haematol 1977; 37: 289-294
  • 12 Finney DJ. Statistical Method in Biological Assay. Griffin and Co. Ltd; London: 1952
  • 13 Kirkwood TB, Snape TJ. Biometric principles in clotting and clot lysis assays. Clin Lab Haematol 1980; 2: 155-167
  • 14 Kirkwood TB L, Barrowcliffe TW. Standardization of Factor VIII. II: A British standard for Factor VIII-related antigen. Br J Haematol 1980; 46: 383-490
  • 15 Kirkwood TB L. Predicting the stability of biological standards and products. Biometrics 1977; 33: 736-742
  • 16 Kirkwood TB. Geometric means and measures of dispersion. Biometrics 1979; 35: 908-909
  • 17 World Health Organization Technical Reports Series. 1977; 610: 12
  • 18 Godfrey R, Rhymes IL, Bidwell E, Barrowcliffe TW. The buffering of anticoagulants for blood collection. Thrombos Diathes Haemorrh 1975; 34: 879-882
  • 19 World Health Organization Technical Reports Series. 1983; 687: 23-24